Launch week offerEnds in00h00m00s

annual Promonthly Pro

Reshma Ramachandran

Yale University

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (10)

Audrey Zhang

Beth Israel Deaconess Medical Center

UNITED STATES

View details

Kasia J. Lipska

Yale University School of Medicine

UNITED STATES

View details

Holly Lynch

Assistant Professor, Clinician-Educator

University of Pennsylvania

UNITED STATES

View details

Caroline Carlin

Research Investigator

University of Minnesota

UNITED STATES

View details

Matthew Herder

Full Professor

Dalhousie University

CANADA

View details

Jeah Jung

Professor

George Mason University

UNITED STATES

View details

Garrett Ash

Assistant Professor

Yale University

UNITED STATES

View details

Kerstin Noëlle Vokinger

Professor and Academic Chair for Regulation in Law, Medicine and Technology

University of Zurich

SWITZERLAND

View details

Aaron Mitchell

Assistant Attending

Memorial Sloan Kettering Cancer Center

UNITED STATES

View details

Joseph Ross

Professor

Yale University School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Reshma Ramachandran

Research Interests

Make your next move.

Explore related searches

Articles (20)

Expanding continuous glucose monitoring's potential from real-time safety to lifestyle support in type 1 diabetes exercise: a proof-of-concept study among adults with low baseline exercise levels

Review of Negotiated Performance Goals and Commitments in Prescription Drug User Fee Act Commitment Letters, 2013-2027

US Food and Drug Administration Officials’ Public Statements on Regulatory Flexibility in New Drug Approval, 2021–2024

Use of low-value cancer care in practices acquired by private equity firms

Characterizing public participation in Prescription Drug User Fee Act reauthorization, 2010–2021

Drug and country characteristics associated with global approval and launch of FDA-approved novel therapeutics

Industry promotion of oncology drugs with accelerated approval that failed confirmatory trials

Representation of Women, Older Adults, and Racial and Ethnic Minoritized Patients in Pivotal Trials for US Food and Drug Administration Novel Oncology Therapeutic Approvals, 2012-2021: Bright Spot Trials and Trends Over Time

Confirmatory evidence supporting single pivotal trial new drug approvals by the Food and Drug Administration, 2015 through 2023

Changes in pharmaceutical industry payments to physicians after New Jersey's 2018 restriction

Flexibility Over Rigor: Stakeholder Acceptance of the Limitations of Confirmatory Studies Following Accelerated Approval

Therapeutic benefit of the most expensive drugs covered by Medicare and Medicaid

Industry payments to US neurologists related to multiple sclerosis drugs and prescribing (2015–2019): a retrospective cohort study

Insulin rationing in states with and without insulin copay caps: a cross-sectional study

FDA Advisory Committee Review of Supplemental Indications and Reasons for Non-Approval, 2008-2022

Medicare Part B and Part D drug eligibility for center for Medicare and Medicaid Services price negotiation under the Inflation Reduction Act: estimates using 2016–2019 data

Harnessing policy to promote inclusive medical product evidence: development of a reference standard and structured audit of clinical trial diversity policies

Funding of evidence included within public comments submitted to inform Medicare national coverage determinations

Characterization of accelerated approval status, trial endpoints and results, and recommendations in guidelines for oncology drug treatments from the National Comprehensive Cancer Network: cross sectional study

Geographic and Demographic Representation in Industry-Sponsored, US-Based Clinical Trials of Systemic Lupus Erythematosus Therapies

Collaborators (10)

Audrey Zhang

Kasia J. Lipska

Holly Lynch

Caroline Carlin

Matthew Herder

Jeah Jung

Garrett Ash

Kerstin Noëlle Vokinger

Aaron Mitchell

Joseph Ross

Make your next move.